Insight Net Receivables from 2010 to 2026
| IMDX Stock | 7.32 0.63 9.42% |
Net Receivables | First Reported 2020-03-31 | Previous Quarter 512 K | Current Value 258 K | Quarterly Volatility 963.6 K |
Check Insight Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insight Molecular's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Selling General Administrative of 11.5 M or Other Operating Expenses of 76 M, as well as many indicators such as Price To Sales Ratio of 18.07, Dividend Yield of 0.0015 or Days Sales Outstanding of 239. Insight financial statements analysis is a perfect complement when working with Insight Molecular Valuation or Volatility modules.
Insight | Net Receivables | Build AI portfolio with Insight Stock |
The evolution of Net Receivables for Insight Molecular Diagnostics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Insight Molecular compares to historical norms and industry peers.
Latest Insight Molecular's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Insight Molecular Diagnostics over the last few years. It is Insight Molecular's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insight Molecular's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Insight Net Receivables Regression Statistics
| Arithmetic Mean | 641,102 | |
| Geometric Mean | 393,090 | |
| Coefficient Of Variation | 106.48 | |
| Mean Deviation | 585,438 | |
| Median | 203,000 | |
| Standard Deviation | 682,630 | |
| Sample Variance | 466B | |
| Range | 1.8M | |
| R-Value | 0.74 | |
| Mean Square Error | 224.2B | |
| R-Squared | 0.55 | |
| Significance | 0.0007 | |
| Slope | 100,149 | |
| Total Sum of Squares | 7.5T |
Insight Net Receivables History
About Insight Molecular Financial Statements
Insight Molecular investors use historical fundamental indicators, such as Insight Molecular's Net Receivables, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Insight Molecular. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 1.9 M | 1.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.